Sectra (OM:SECT B) Shares Moved, What Is Behind The Attention?
Sectra (OM:SECT B) just logged another client go live, with Northeast Georgia Medical Center now running its Sectra One Cloud enterprise imaging platform for radiology, breast imaging, and cardiology.
Sectra’s recent client wins come against a backdrop of a 19.03% year-to-date share price return. The 1-year total shareholder return is down 6.72%, while the 3-year total shareholder return is 125.64%, suggesting long-term momentum despite some shorter-term cooling.
Scan how Sectra’s momentum compares with other healthcare IT players by running your own shortlist from the 134 healthcare AI stocks.
Sectra shares have cooled over 1 year after a strong 3-year run, even as new cloud wins keep rolling in. Does that mix of momentum and recent weakness still leave enough potential value in the shares to justify the risk?
Most Popular Narrative: 16% Undervalued
Sectra is trading at SEK285.2 against a widely followed narrative fair value of SEK340, which frames the current debate around whether the recent share price pause matches the long term story.
Transition to an as-a-service model is expected to enhance future revenue stability and growth, with a significant increase in recurring cloud revenue anticipated as products move from hardware-based to cloud solutions. This transition is likely to impact revenue positively in the long term.
See why 4 investors see Sectra as 16% undervalued.
Result: Fair Value of SEK340 (UNDERVALUED)
Still, Sectra’s shift to SaaS and its reliance on very large contracts could create bumpy quarters that challenge the current cloud-driven narrative.
Find out about the key risks to this Sectra narrative.
Another View on Sectra’s Valuation
The analyst narrative points to Sectra trading below a SEK340 fair value, yet the current P/E of 88.8x paints a very different picture. That multiple sits well above the global Healthcare Services average of 27.4x and a fair ratio of 35.5x, which implies meaningful valuation risk if sentiment cools.
That gap raises a simple question for investors. Is the story strong enough to keep supporting a premium this far above both peers and the fair ratio, or is it time to stress test those expectations with your own assumptions before acting on the narrative?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If the mixed signals around Sectra leave you uncertain, that is the point. To get a clearer view, move quickly to review the full picture for yourself through the 2 key rewards and 1 important warning sign.
Looking for more Sectra sized investment ideas?
Do not stop at Sectra. Broaden your watchlist with fresh, data driven ideas that could sharpen your overall portfolio positioning and keep you ahead of the crowd.
- Target resilience by scanning a 228 resilient stocks with low risk scores set that aims to limit drawdowns while still keeping you exposed to meaningful upside potential.
- Hunt for mispriced opportunities through a 181 high quality undervalued stocks that filters for solid fundamentals paired with valuations that may not fully reflect them yet.
- Strengthen your defensive core by focusing on a list of solid balance sheet and fundamentals (202 results) that can help you sidestep fragile businesses before the market punishes them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com